Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN116462682B enables high-purity tofacitinib impurity production with simplified workflow and substantial cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104693092A reveals a one-step synthesis for PTP1B inhibitors. Discover cost reduction and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN105779555B details a one-step microbial conversion for prednisolone intermediates, offering significant cost reduction and supply chain efficiency for pharmaceutical manufacturers.
Novel asymmetric substitution route for Dapoxetine intermediate. High yield, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN101585840A details a novel synthesis for optically pure alpha-ketoacyl harringtonine intermediates, offering improved yields and scalable purification for anticancer drug production.
Novel patent CN105622699A offers precious metal-free route for steroidal intermediates, ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105622538B reveals one-pot synthesis improving purity and yield. Offers supply chain stability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN113548999B details a Pd-catalyzed route for chiral oxindoles. Offers high enantioselectivity and scalable antiviral intermediate production.
Patent CN102851238B reveals enzymatic hydrolysis breakthrough. Offers high purity and cost reduction in Pharmaceutical Intermediates manufacturing for global supply chains.
Novel process for 1,2-substituted 3,4-dioxo-1-cyclobutene compounds offering improved safety and scalability for pharmaceutical manufacturing supply chains.
Patent CN110407737B reveals a streamlined Grignard route for cyproheptadine hydrochloride, offering higher purity and safer manufacturing for global supply chains.
Novel patent CN115677771A offers efficient fosfomycin intermediate production with reduced costs and high purity for reliable pharmaceutical supply chains.
Patent CN114085219A details a high-ee synthesis of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane. This route offers superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Patent CN1639172A details novel silicon-based reagents for high-ee alcohol synthesis, offering scalable routes for complex pharmaceutical intermediates manufacturing.
Patent CN100588643C details a scalable synthesis for novel disubstituted adamantyl retinoic acids. Offers high purity, simplified processing, and cost-effective API manufacturing solutions.
Novel synthesis method for 1-(3-methoxypropyl)-4-piperidinamine offering high purity and cost efficiency for pharmaceutical supply chains globally and reliably.
Patent CN104262309A details an iron-catalyzed chromone synthesis. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability for global buyers.
Patent CN116789664A details a metal-free photocatalytic route for trifluoromethyl benzimidazoloisoquinoline analogues, offering cost-effective and scalable manufacturing solutions.
Patent CN109081810A details a robust 7-step synthesis for Lorlatinib intermediates. Achieves high purity and scalable production for global pharmaceutical supply chains.